Ranitidine duty suspension
Executive Summary
International Trade Commission study on domestic economic impact of duty suspension requested for Senate Finance Committee by Jan. 18. Duty suspension legislation (HR 3130) for the active ingredient in Glaxo's Zantac was stopped in the 101st Congress by an objection from SmithKline Beecham. Study has been requested to assess whether duty suspension for the ingredient would unfairly affect Tagamet ("The Pink Sheet" Oct. 1, T&G-4).